A little over a year ago, I got an email from my wife saying she had had two injections.
She was not alone.
About 10% of men with hypogonadism in the U.S. have a history of a cycle of testosterone therapy, which includes the injection of the drug to help control symptoms and help regulate levels.
While the medication does not cause any harm, many doctors believe it is not necessary and could lead to a serious condition such as low libido, weight gain and an inability to exercise.
My wife said she is still experiencing some of the same symptoms and she needs to see a doctor for her treatment.
It was a rare diagnosis, but one that was becoming more common with men with testosterone cyporionate syndrome.
I did not have the symptoms or experience that my wife did.
But in the years since, I have had a series of medical appointments where I have been asked, “Do you need testosterone?”
It is not a new question for me.
I have always been told that my condition is a symptom of my hormone deficiency.
My symptoms are mild, and they are not as noticeable as the ones she had.
But the symptoms are there and they can become serious if left untreated.
When a man with a testosterone cyporter cycle stops taking his medication, his body stops responding to it.
It can cause anorexia and weight gain.
And the symptoms can worsen with the addition of other medications.
“The first thing that usually happens is that testosterone can build up in the body, and then your body tries to fix it, but that can’t happen because the hormone can’t build up,” said Dr. Peter B. Vranich, a clinical professor of medicine at Columbia University.
“Then it can build more and more and then suddenly it will start to go off, and that’s when your body will start having trouble.”
A man’s testosterone cycle can also cause other health issues, including diabetes, cardiovascular disease and infertility.
It is a risk factor for prostate cancer and low testosterone.
But unlike some other disorders, it is also not a risk for Alzheimer’s disease.
Dr. Vrenich is working on a new drug that is based on the peptide, cypiotropin, that testosterone cyproterone acetate (CPA) and its analogs cypions can produce.
It also helps to reduce the amount of testosterone in the blood, and it can also help to decrease the risk of heart disease.
The CPA drug is a more potent form of testosterone than testosterone cyploids, so its effects will last longer and are more permanent.
Dr., Vranch says that he thinks testosterone therapy is just a matter of time.
“It’s a good idea, I think, because you know, the human body is not designed to be in a condition where we’re constantly being exposed to a hormone that’s going to be causing harm,” he said.
And in fact, there is no evidence that testosterone therapy has any risk of causing serious side effects.
It may be worth it, though.
Varenka Van Der Werff and Van Der Wiel are the directors of the New York University Center for Endocrinology and Diabetes Research.
The views expressed are the authors alone.